27 May 2025
QVQ offers the production and purification of single-domain antibodies (sdAbs or VHHs) and VHH-based fusion proteins, using a range of expression systems including E. coli, S. cerevisiae, and ExpiHEK cells.
Recombinant antibodies play a fundamental role in molecular biology, biotechnology, and pharmaceutical R&D. With the flexibility to express sdAbs in bacterial, yeast, or mammalian cells, we tailor our approach to meet the specific needs of each application.
We’re proud to have expanded our capabilities with the addition of ExpiHEK cell-based expression—providing an optimal environment for proper folding and functionality of VHH and VHH-Fc proteins in particular. This enhancement supports our mission to deliver high-quality VHH-based molecules in a cost- and time-efficient manner.
Partnering with QVQ means gaining a trusted expert in single-domain antibody discovery and development. From lead characterization, antibody engineering, humanization, affinity maturation, we help researchers achieve their goals with precision and speed.
